论文部分内容阅读
目的:分析在我院内分泌科筛查的1 162例2型糖尿病患者各种慢性并发症的发生情况。方法:糖尿病患者在初次来我院内分泌科就诊时均进行糖尿病慢性并发症筛查和既往筛查史的调查,区分既往主动和被动筛查史,统计和分析2005-2012年纳入的1 162例2型糖尿病患者各种慢性并发症的患病率、本筛查中的发现率以及既往主动和被动筛查率。结果:2005-2012年,既往总筛查率随年份变化的趋势明显,呈升高态势(趋势卡方值为322.82,P=0.000);按两个年份段相比:2009-2012年份段既往总筛查率和主动筛查率明显高于2005-2008年份段(32.47%比20.13%;14.21%比1.53%);但总体而言,既往总筛查率(均值26.43%)特别是主动筛查率(均值8.41%)不高;各种慢性并发症的患病率从29.35%到86.92%不等,无阳性发现者仅占6.8%;本筛查对各种慢性并发症的发现率从21.43%到68.62%不等,尿微量白蛋白/Cr比值升高的发现率最高,其次为糖尿病性视网膜病变。结论:糖尿病慢性并发症的高发病率与目前较低的筛查率形成明显的对比,主动筛查是早期发现各种慢性并发症的必要手段。应加强糖尿病患者主动筛查的意识,医院及相关部门应开展规范的筛查管理,以降低慢性并发症的危害。
OBJECTIVE: To analyze the incidence of various chronic complications in 1 162 type 2 diabetic patients screened in the Department of Endocrinology in our hospital. Methods: Patients with diabetes mellitus were enrolled in the endocrine department of our hospital for the first time to conduct a survey of chronic complications of diabetes and previous screening history survey, the distinction between the past active and passive screening history, statistics and analysis of 2005 included 1 162 cases The prevalence of various chronic complications in patients with type 2 diabetes, the prevalence of this screening and past active and passive screening rates. Results: From 2005 to 2012, the past screening rate showed a clear trend of change with years, showing an upward trend (trend chi square value was 322.82, P = 0.000); compared with two years: 2009-2012 period past The overall screening rate and active screening rate were significantly higher than those in 2005-2008 (32.47% vs. 20.13%; 14.21% vs. 1.53%). Overall, however, the overall past screening rate (mean 26.43% (8.41% average) were not high; the prevalence of various chronic complications ranged from 29.35% to 86.92%, with only 6.8% of those with no positive findings. The detection rate of various chronic complications in this screening ranged from 21.43% to 68.62%, urine microalbumin / Cr ratio was the highest rate of detection, followed by diabetic retinopathy. CONCLUSIONS: The high incidence of chronic complications of diabetes is in striking contrast with the current low screening rates, and active screening is an essential means of early detection of various chronic complications. Should strengthen the awareness of active screening of patients with diabetes, hospitals and relevant departments should conduct standardized screening management to reduce the risk of chronic complications.